Modulating the activity of the proNGF-p75NTR-sortilin complex may hold the key to reducing neuronal apoptosis while promoting neuronal survival and functional recovery, thus presenting a new avenue for PD treatment. This evidence concerns the gene SORT1 and Parkinson disease.